Globe Life (GL) Q1 2025 earnings summary

Executive summary

• Net income for Q1 2025 was $255 million ($3.01 per share), up slightly from $254 million ($2.67 per share) a year ago; diluted EPS rose 13% year-over-year.

• Net operating income was $259 million ($3.07 per share), up 10% per share but down 2% year-over-year in total, exceeding internal projections.

• Total premium revenue grew 5% to $1.2 billion, with life premium up 3% to $830 million and health premium up 8% to $370 million.

• Book value per share excluding AOCI rose 11% year-over-year to $87.92.

• 1.5 million shares were repurchased for $177 million at an average price of $121.70 per share.

Financial highlights

• Total revenue for Q1 2025 was $1.48 billion, up from $1.42 billion in Q1 2024.

• Net investment income declined 1% to $281 million; excess investment income fell 18% to $35.9 million.

• Life underwriting margin increased 9% to $337 million; health underwriting margin declined 10% to $85 million due to higher claim costs.

• Insurance administrative expenses rose 9% to $87.5 million, or 7.3% of premium, due to higher IT, employee, and legal costs.

• Operating cash flow was $432 million, up from $351 million in Q1 2024.

Outlook and guidance

• Net operating earnings per diluted share for 2025 reaffirmed at $13.45-$14.05, representing 11% growth at midpoint.

• Life premium revenue expected to grow ~4% for 2025; life underwriting margin as a percent of premium projected at 42%-44%.

• Health premium revenue expected to grow 7.5%-8.5%, with health underwriting margin as a percent of premium at 24%-26%.

• Share repurchases for 2025 anticipated at $600 million-$650 million; consolidated RBC ratio targeted at 300%-320%.

• Excess cash flow for 2025 expected at $785 million-$835 million; run rate for future years projected at $500 million-$600 million.